Q Therapeutics
is a biopharmaceutical company that engages in developing human cell-based therapies to treat central nervous system disorders... Read moreQ Therapeutics
is a biopharmaceutical company that engages in developing human cell-based therapies to treat central nervous system disorders... Read more
News
Oct 02, 2018
MassDevice
Q Therapeutics: InVivo inks joint research deal with cell therapy dev Q Therapeutics
Sep 26, 2018
4-traders
Q Therapeutics: Q Therapeutics Receives Orphan Drug Designation for Transverse Myelitis
Apr 23, 2018
Contract Pharma
Q Therapeutics: Q Therapeutics, REPROCELL Form MAGiQ Therapeutics
Dec 13, 2017
PharmiWeb
Q Therapeutics: Q Therapeutics Announces Research Collaboration With REPROCELL
Aug 07, 2017
BioSpace
Q Therapeutics: Q Therapeutics, Inc. Expands Board Of Directors With Appointment Of Dr. As Independent Member
Aug 06, 2017
StreetInsider
Press Release: Q Therapeutics : Q Therapeutics Expands Board of Directors With Appointment of Dr. Tom Parks as Independent Member
Jul 25, 2017
BioSpace
Q Therapeutics: Q Therapeutics, Inc. Release: FDA Allows Q-Cells For First-In-Human Transverse Myelitis Trial
Jul 17, 2015
CONTRACT PHARMA
Q Therapeutics: Goodwin Biotechnology Completes cGMP Manufacturing of an IgM Monoclonal Antibody
Jul 15, 2015
BIOPHARMA-REPORTER
Q Therapeutics: CNS drugmaker teams with CDMO on ALS mAb candidate
Jul 13, 2015
PR NEWSWIRE
Press Release: Q Therapeutics : Goodwin Biotechnology Announces the Completion of cGMP Manufacturing of an IgM Monoclonal Antibody and IgM : Ligand Conjugate for Q Therapeutics, and Successful Clearance of Q Therapeutics' IND Submission for Q-Cells® Cell Therapy in ALS
Q Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10